A group of 19 health sciences organizations and associations asked for a “coherent” life sciences strategy and increased collaboration this Monday in an open letter addressed to Prime Minister Justin Trudeau. The letter follows a $415-million federal investment into a partnership with French pharmaceutical manufacturer Sanofi to build an influenza vaccine manufacturing facility in Toronto.
Person: Jason Field
A pandemic-era Ontario budget includes limited new funding for research and innovation.
Ontario has announced a life sciences venture capital initiative to provide provincial firms with much-needed capital to grow their business. The Ontario Capital Growth Corporation (OCGC), the agency managing the province’s VC interests, is seeking fund managers who can leverage the province’s $50-million investment.
Ontario’s key life sciences players are calling for greater coordination to help the sector grow by more effectively exploiting the sector’s untapped potential.